HAVCR2 and hepatocellular carcinoma: Third, Oxysophocarpine sensitized the immunotherapy effect of anti‐Lag‐3 without side effect, whereas had a little effect with TIGIT, PD‐1, or Tim‐3 blockade against HCC cells.